Diagnosis & Management of Diabetic Eye Disease A. Paul Chous, M.A., O.D., F.A.A.O. Tacoma, WA Specializing in Diabetes Eye Care & Education Part 2.

Slides:



Advertisements
Similar presentations
TIME TO ACT Type 2 diabetes, the metabolic syndrome and cardiovascular disease in Europe CONTENTS Section One: Background to type 2 diabetes, the metabolic.
Advertisements

Evan (Jake) Waxman MD PhD
Prevalence of Diabetic Retinopathy In Diabetic patients cared for at the Family Care Center at RCRMC Kam Chan, DO [ role of BP & glycemic control ]
More Facts on Fats Lipids and Health.
Diabetes mellitus complications & morphology. Complications of diabetes  In type 1 &2 diabetes  Variable onset, severity,organs of involvement  Macrovascular.
S-KHALILZADEH. BIOCHEMISTRY AND MOLECULAR CELL BIOLOGY All forms of diabetes, both inherited and acquired, are characterized by hyperglycemia, a relative.
Adiposity in CVD. Role of adipose tissue in atherogenesis Adapted from de Luca C, Olefsky JM. Nat Med. 2006;12:41-2. Lau DCW et al. Am J Physiol Heart.
Aging of the Cardiovascular System (continued)
Isfahan University Of Medical Sciences
به نام خداوند جان و خرد. دکتر نادر طاهری متخصص داخلی فوق تخصص غدد Refrence:ADA(2012) and William textbook of endocrinology.
Diabetic Retinopathy Steven Sanislo, M.D. Assistant Professor Stanford University Department of Ophthalmology.
Topic assignment : medical ophthalmology
Complications of Diabetes Mellitus Dr Rodney Itaki Lecturer Anatomical Pathology Discipline University of Papua New Guinea School of Medicine & Health.
Regarding type 1 diabetes mellitus, which one statement is correct: Regarding type 1 diabetes mellitus, which one statement is correct: a. Most commonly.
Diabetes Mellitus (Lecture 2). Type 2 DM 90% of diabetics (in USA) Develops gradually may be without obvious symptoms may be detected by routine screening.
Hyperglycemia at the Vessel Wall. Potential hyperglycemia-induced tissue damage Brownlee M. Diabetes. 2005;54: Repeated acute changes in cellular.
WHY REGULATE PLASMA GLUCOSE? Set Point: mg/100 ml plasma Glucose is virtually the only fuel the brain can use to make ATP (also ketones) If plasma.
Liberty Medical. Microvascular and Macrovascular.
Reem Sallam, MD, MSc. PhD Clinical Chemistry Unit, Pathology Dept. College of Medicine, King Saud University.
Dr. Amr S. Moustafa, MD, PhD Clinical Chemistry Unit, Pathology Dept. College of Medicine, King Saud University.
Denise Coffey MSN, RN.  American Diabetes Association:  Nearly 26 million Americans have diabetes and an estimated 79.
Anatomy and physiology of t2d Lesson Five Today we will… Make a human body poster that shows how t2d affects organs and body systems Look at treatment.
VBWG Insulin Resistance and Cardiovascular Disease: New Perspectives From Vascular Biology.
Diagnosis & Management of Diabetic Eye Disease Paul Chous, M.A., O.D., F.A.A.O. Specializing in Diabetes Eye Care & Education Part 3.
Diagnosis & Management of Diabetic Eye Disease Part 1 A. Paul Chous, M.A., O.D., F.A.A.O. Tacoma, WA Specializing in Diabetes Eye Care & Education.
Diagnosis & Management of Diabetic Eye Disease Part 7 A. Paul Chous, M.A., O.D., F.A.A.O. Tacoma, WA Specializing in Diabetes Eye Care & Education.
PPAR gamma system and glucose: metabolism. Shared metabolic abnormalities with insulin resistance and endothelial dysfunction Glucotoxicity Lipotoxicity.
Plasminogen-Activating Inhibitor-1 (PAI-1) High PAI-1 associated with: Obesity (especially visceral), possible fatty liver. 2,3,4 Inflammation and oxidative.
Diagnosis & Management of Diabetic Eye Disease A. Paul Chous, M.A., O.D., F.A.A.O. Tacoma, WA Specializing in Diabetes Eye Care & Education Part 6.
Type 2 diabetes Derek LeRoith. Insulin Resistance: A Core Defect of The Metabolic Syndrome Insulin Resistance Dyslipidemia Obesity Hypertension Dysfibrinolysis.
The Diabetic Athlete: Implications, participation Jason Blackham, MD August 21, 2008 Sports Medicine Rounds.
IR and Hyperinsulinemia Insulin Resistance: A Survival Mechanism, Gone Awry Stan Schwartz MD,FACP Affiliate, Main Line Health System Emeritus, Clinical.
Diagnosis & Management of Diabetic Eye Disease A. Paul Chous, M.A., O.D., F.A.A.O. Tacoma, WA Specializing in Diabetes Eye Care & Education Part 5.
Diabetes Complications and Control Trial (DCCT) Tight control of blood glucose levels significantly decreased risk of diabetic complications. Finding.
Diabetes Mellitus 101 for Cardiologists (and Alike): 2015
IR and Hyperinsulinemia Insulin Resistance: A Survival Mechanism, Gone Awry Stan Schwartz MD,FACP Affiliate, Main Line Health System Emeritus, Clinical.
Double Jeopardy. International Diabetes Federation Diabetes State of raised blood glucose (hyperglycaemia) associated with premature mortality Pancreas.
Josephine Carlos-Raboca, M.D. Makati Medical Center
Hyperglycemia The Defining Feature of Diabetes
Diabetes Mellitus Type 2
Cardiovascular Disease
Cardiovascular pathophysiology III
Overview of advanced glycation end-products (AGEs) Part 2
Committed to excellence in eye care Smoking Cessation Services in High Street Optometric Practices.
Diagnosis & Management of Diabetic Eye Disease A. Paul Chous, M.A., O.D., F.A.A.O. Tacoma, WA Specializing in Diabetes Eye Care & Education Part 4.
HANDBOOK OF DYSLIPIDEMIA AND ATHEROSCLEROSIS Part One Professor Jean-Charles Fruchart Department of Atherosclerosis (Inserm UR545) Pasteur Institute of.
Utilizing Anti-diabetic Agents to Manage Cardiovascular Disease in T2DM Patients James LaSalle, D.O., FAAFP.
Prevalence of Diabetic Retinopathy
Dr.Ravi kant Associate Professor Medicine ,AIIMS Rishikesh
WHAT ABOUT COMPLICATIONS OF DIABETES?
CLS 223.
Metabolic Changes in Diabetes Mellitus
Unified Theory of Diabetes and All Its Complications
Metabolic Changes in Diabetes Mellitus
Heart Health & Diabetes
Genetic Influences Independent Accelerators
366 میلیون نفر در جهان مبتلا به دیابت هستند.
Ch 13.6: Blood Vessels 13.7: Athrosclerosis and Cardiac Arrhythmias
In and Out: Adipose Tissue Lipid Turnover in Obesity and Dyslipidemia
WHAT ABOUT COMPLICATIONS OF DIABETES?
Why Focus on Complications?
Advanced Nutrition Diet and Cardiovascular Disease 1
Figure 2 Organ crosstalk in the pathophysiology
Treatment of Depression in Patients with Coronary Heart Disease
Diabetes and atherosclerosis
John R. Petrie, MD, PhD, Tomasz J. Guzik, MD, PhD, Rhian M
In and Out: Adipose Tissue Lipid Turnover in Obesity and Dyslipidemia
Several genetic, environmental, lipid partitioning, and biochemical factors, shown on the left, promote the development of subclinical inflammation and.
Christian Rask-Madsen, George L. King  Cell Metabolism 
Presentation transcript:

Diagnosis & Management of Diabetic Eye Disease A. Paul Chous, M.A., O.D., F.A.A.O. Tacoma, WA Specializing in Diabetes Eye Care & Education Part 2

Biochemical Influences In large vessels: In large vessels: Free fatty acids (FFAs) cause inflammation, dyslipidemia, and atherosclerosis Free fatty acids (FFAs) cause inflammation, dyslipidemia, and atherosclerosis Small, dense LDL Small, dense LDL Increased blood viscosity & vessel rigidity causes HTN Increased blood viscosity & vessel rigidity causes HTN Increased platelet adhesion Increased platelet adhesion

Visceral Adipose Tissue Visceral fat releases substances that cause insulin resistance and mobilize non-esterified fatty acids (Free Fatty Acids) Visceral fat releases substances that cause insulin resistance and mobilize non-esterified fatty acids (Free Fatty Acids) Insulin resistance  Hyperglycemia Insulin resistance  Hyperglycemia FFAs are oxidized by vascular endothelium  inflammatory cytokines (PAI-1, CRP & more) FFAs are oxidized by vascular endothelium  inflammatory cytokines (PAI-1, CRP & more)

Large vessel A Unifying Mechanism for Microvascular and Macrovascular Diabetes Complications  FFAs  Glu Polyol Hexosamine PKC AGEs Adapted source: Michael Brownlee, M.D. Small vessel

Hemodynamic Influences Conditions that increase retinal blood flow increase the risk of severe DRT –H–H–H–Hyperglycemia –S–S–S–Systemic hypertension –P–P–P–Pregnancy –O–O–O–Ocular hypotension

Other Influences Genetic Susceptibilities Genetic Susceptibilities Haptoglobin Haptoglobin Lipid SNPs Lipid SNPs Endocrine factors Endocrine factors Growth hormone (GH) and Insulin-like growth factors (IGF) Growth hormone (GH) and Insulin-like growth factors (IGF)

Diabetic Eye Disease Diabetes Epidemic Microvascular Biochemistry PKC, AGEs, Polyol Flux, Hexosamine Macrovascular Biochemistry Glycated LDL, sticky platelets, CRP CAMs/leukocyte adhesion, 4 pathways Increased Blood Flow: Shear Stress Shunting Factors Contributing to Diabetic Eye Disease Hypertension Pericyte Damage Hormonal Factors & Individual Genetic Susceptibility

It’s Not Just The Eye….. PDR Doubled the Risk of Cardiovascular Death in T1DM Over 8 Years (EURODIAB Complications Study, 2005) In T2DM, NPDR Conferred X Increased Risk of Death & PDR Increased Risk of Death 3-5 Fold Over 18 years (Diabetes Care 2007 Feb)

Diagnosis & Management of Distinct Entities “Diabetic Eye Disease” refers to ocular pathologies more commonly seen in patients with diabetes “Diabetic Eye Disease” refers to ocular pathologies more commonly seen in patients with diabetes All of these conditions are attributable, at least in part, to chronic hyperglycemia All of these conditions are attributable, at least in part, to chronic hyperglycemia

Ocular Diseases Associated With Diabetes Cataract Cataract Keratopathy Keratopathy Efferent Cranial Neuropathy Efferent Cranial Neuropathy Glaucoma Glaucoma Ischemic Optic Neuropathy Ischemic Optic Neuropathy Retinal Vascular Occlusion Retinal Vascular Occlusion Diabetic Retinopathy Diabetic Retinopathy